Recurrent panniculitis around eyelids, shin, and forearms, in association with leukocytosis, and elevated ESR and C-reactive protein (CRP) led to treatment with treatment with JAK inhibitor (JAKi), tofacitinib at 4 years of age. The gene discussed is ESR1; the disease is panniculitis.